1. Home
  2. MBBC vs RNXT Comparison

MBBC vs RNXT Comparison

Compare MBBC & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MBBC

Marathon Bancorp Inc.

N/A

Current Price

$15.00

Market Cap

43.4M

Sector

Finance

ML Signal

N/A

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.87

Market Cap

38.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBBC
RNXT
Founded
1902
2012
Country
United States
United States
Employees
35
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.4M
38.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MBBC
RNXT
Price
$15.00
$0.87
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.25
AVG Volume (30 Days)
7.9K
220.3K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
N/A
$1,123,000.00
Revenue This Year
N/A
$194.66
Revenue Next Year
N/A
$279.78
P/E Ratio
$47.11
N/A
Revenue Growth
N/A
2511.63
52 Week Low
$9.97
$0.70
52 Week High
$15.79
$1.45

Technical Indicators

Market Signals
Indicator
MBBC
RNXT
Relative Strength Index (RSI) 51.87 45.13
Support Level $12.90 $0.81
Resistance Level $15.60 $1.07
Average True Range (ATR) 0.38 0.05
MACD -0.06 -0.01
Stochastic Oscillator 32.10 28.88

Price Performance

Historical Comparison
MBBC
RNXT

About MBBC Marathon Bancorp Inc.

Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: